cytosine has been researched along with Angiogenesis, Pathologic in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "VEGF promoter polymorphisms +405 and -460 were examined in 596 CHF patients enrolled in the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF) study and in 187 healthy controls." | 5.11 | The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. ( De Boer, RA; Hall, AS; van der Meer, P; van der Steege, G; van Veldhuisen, DJ; Voors, AA; White, HL, 2005) |
| "The leukemias are complex diseases with a wide range of clinical, morphologic, biologic, molecular, and clinical features and a consequent array of possible responses to any given intervention." | 2.41 | Novel agents for the therapy of acute leukemia. ( Giles, FJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shiva Shankar, TV | 1 |
| Willems, L | 1 |
| Liu, CM | 1 |
| Yeh, CJ | 1 |
| Yu, CC | 1 |
| Chou, MY | 1 |
| Lin, CH | 1 |
| Wei, LH | 1 |
| Lin, CW | 1 |
| Yang, SF | 1 |
| Chien, MH | 1 |
| Liekens, S | 2 |
| van der Meer, P | 1 |
| De Boer, RA | 1 |
| White, HL | 1 |
| van der Steege, G | 1 |
| Hall, AS | 1 |
| Voors, AA | 1 |
| van Veldhuisen, DJ | 1 |
| Amine, A | 1 |
| Vozenin-Brotons, MC | 1 |
| Abdulkarim, B | 1 |
| Violot, D | 1 |
| Aubel, C | 1 |
| Bourhis, J | 1 |
| Neyts, J | 1 |
| De Clercq, E | 1 |
| Verbeken, E | 1 |
| Ribatti, D | 1 |
| Presta, M | 1 |
| Giles, FJ | 1 |
3 reviews available for cytosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network.
Topics: Acetylation; Animals; Cytosine; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gen | 2014 |
The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cidofovir; Cycloh | 2002 |
Novel agents for the therapy of acute leukemia.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Azacitidine; Cysteine Endopeptidases; Cytosine; Deci | 2002 |
1 trial available for cytosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.
Topics: Adrenergic beta-Antagonists; Case-Control Studies; Cohort Studies; Cytosine; Female; Follow-Up Studi | 2005 |
3 other studies available for cytosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Topics: 3' Untranslated Regions; Adenine; Areca; Carcinogens; Carcinoma, Squamous Cell; Case-Control Studies | 2012 |
Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines.
Topics: Angiogenic Proteins; Antineoplastic Agents; Cell Line, Tumor; Cidofovir; Cytosine; Down-Regulation; | 2006 |
Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Apoptosis; Brain Neoplasms; Cell Division; Chick E | 2001 |